United Therapeutics' Phase 3 ralinepag cut clinical worsening risk by 55% and the company says the drug could be a $2B rival to J&J's Uptravi.

A Triangle Business Journal ranking shows the region’s 25 biggest VC backers raised about $1.5B in 2025, highlighting concentrated capital and a life‑sciences tilt.

Duke researchers found that resident immune cells in the eye’s drainage tissues clear debris and help control pressure; removing them in mice raised intraocular pressure. The work, published in Immunity, points to a new target for glaucoma therapies.

Ralliant opened its global headquarters in Raleigh’s North Hills and kicked off a hiring push for up to 180 high‑paying corporate roles supported by state incentives.

A Carrboro mother and UNC researchers are testing an enzyme therapy that aims to slow brain decline in children with Hunter syndrome.

A UNC-developed closed-loop headset tuned brain rhythms and produced large symptom drops in a small pilot; researchers and company partners are planning randomized trials.

Raleigh startup Slate Medicines closed a $130M Series A to develop SLTE‑1009, an anti‑PACAP antibody for migraine prevention. The company plans a Phase 1 trial in mid‑2026.

CommercialCafe’s ranking puts Raleigh at No. 3 and Durham in the top 10, highlighting the Research Triangle’s job density, pay and company growth.

The Gates Foundation joined a strategic round for Ten63, the Research Triangle AI drug‑discovery startup, which says the funding pushes its announced backing past $45M and ties support to HPV work.

AT&T reports a cell outage in Durham that could take days to fix. Here’s what to know and how to stay connected while technicians investigate.

North Carolina hit No. 1 for tech job growth as Charlotte added roughly 37,000 jobs and digital roles spread into smaller metros. Policymakers say training and infrastructure will determine whether the momentum lasts.

Raleigh Police Department will upgrade to Axon Records for digital records management and adopt the Taser 10 device following the Raleigh City Council's approval.

Raleigh tests an AI program to enhance traffic light timing and road safety by analyzing data from city cameras, aimed at easing congestion and potentially saving costs.